DK1971339T3 - Kombination af triazinderivater og insulinsekretionsstimulatorer - Google Patents

Kombination af triazinderivater og insulinsekretionsstimulatorer

Info

Publication number
DK1971339T3
DK1971339T3 DK06829703.5T DK06829703T DK1971339T3 DK 1971339 T3 DK1971339 T3 DK 1971339T3 DK 06829703 T DK06829703 T DK 06829703T DK 1971339 T3 DK1971339 T3 DK 1971339T3
Authority
DK
Denmark
Prior art keywords
combination
insulin secretion
triazine derivatives
secretion stimulators
stimulators
Prior art date
Application number
DK06829703.5T
Other languages
Danish (da)
English (en)
Inventor
Gerard Moinet
Daniel Cravo
Didier Mesangeau
Original Assignee
Poxel Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poxel Sas filed Critical Poxel Sas
Application granted granted Critical
Publication of DK1971339T3 publication Critical patent/DK1971339T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06829703.5T 2006-01-13 2006-12-18 Kombination af triazinderivater og insulinsekretionsstimulatorer DK1971339T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0600342A FR2896157B1 (fr) 2006-01-13 2006-01-13 Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
PCT/EP2006/012182 WO2007079914A2 (en) 2006-01-13 2006-12-18 Combination of triazine derivatives and insulin secretion stimulators

Publications (1)

Publication Number Publication Date
DK1971339T3 true DK1971339T3 (da) 2012-02-20

Family

ID=36648317

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06829703.5T DK1971339T3 (da) 2006-01-13 2006-12-18 Kombination af triazinderivater og insulinsekretionsstimulatorer

Country Status (21)

Country Link
US (1) US8227465B2 (https=)
EP (1) EP1971339B1 (https=)
JP (1) JP5702911B2 (https=)
KR (1) KR20080091366A (https=)
CN (1) CN101355949A (https=)
AR (1) AR059030A1 (https=)
AT (1) ATE540682T1 (https=)
AU (1) AU2006334731B2 (https=)
BR (1) BRPI0620923A2 (https=)
CA (1) CA2636837C (https=)
CY (1) CY1112674T1 (https=)
DK (1) DK1971339T3 (https=)
EA (1) EA016649B1 (https=)
ES (1) ES2378469T3 (https=)
FR (1) FR2896157B1 (https=)
IL (1) IL192596A (https=)
PL (1) PL1971339T3 (https=)
PT (1) PT1971339E (https=)
SI (1) SI1971339T1 (https=)
WO (1) WO2007079914A2 (https=)
ZA (1) ZA200806938B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0923373B8 (pt) * 2008-12-12 2021-05-25 Merck Patent Gmbh composições farmacêuticas compreendendo uma combinação de insulina com derivados de triazina, e uso da dita combinação
FR2948028B1 (fr) * 2009-07-17 2011-12-02 Merck Sante Sas Association d'un inhibiteur de l'echangeur sodium-proton et d'un derive amine de dihydro-1,3,5-triazine
RU2550798C2 (ru) * 2011-05-12 2015-05-10 Василий Иосифович Зоря Способ стимуляции секреции инсулина
FR2987268B1 (fr) * 2012-02-28 2014-07-11 Ammtek Formulations liquides de sulfamides hypoglycemiants
TWI748945B (zh) * 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
CA3078163A1 (en) 2017-10-02 2019-04-11 Poxel Methods of treating heart failure with preserved ejection fraction
CA3102412A1 (en) 2018-06-06 2019-12-12 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
AU2019286326A1 (en) * 2018-06-14 2020-12-10 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
USD945167S1 (en) 2018-10-31 2022-03-08 Kimberly-Clark Worldwide, Inc. Paper sheet
JP7093473B2 (ja) * 2019-12-13 2022-06-29 住友ファーマ株式会社 製造性及び溶出性に優れた小型錠剤
US12280125B2 (en) 2022-09-09 2025-04-22 Imam Abdulrahman Bin Faisal University Method for delivering insulin

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (it) 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
FR2781152B1 (fr) 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
USRE40876E1 (en) * 1999-06-21 2009-08-18 Eli Lilly And Company Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof
US6559188B1 (en) * 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
US6586438B2 (en) * 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
PT1741446E (pt) * 2000-01-21 2008-05-09 Novartis Pharma Ag Combinações incluindo inibidores da dipeptidilpeptidase-iv e agentes anti-diabéticos
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
ITFI20010126A1 (it) 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
ATE361065T1 (de) * 2002-01-25 2007-05-15 Silanes Sa De Cv Lab Pharmazeutische zusammensetzung zur kontrolle des blutzuckers bei patienten mit typ 2 diabetes
US7985422B2 (en) * 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
US20040147564A1 (en) * 2003-01-29 2004-07-29 Rao Vinay U. Combinations of glimepiride and the thiazolidinedione for treatment of diabetes
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
KR20060119927A (ko) * 2003-09-02 2006-11-24 프로시디온 리미티드 혈당 조절을 위한 조합 요법

Also Published As

Publication number Publication date
EA200801665A1 (ru) 2008-12-30
JP2009523139A (ja) 2009-06-18
ES2378469T3 (es) 2012-04-12
IL192596A0 (en) 2009-09-22
US8227465B2 (en) 2012-07-24
WO2007079914A3 (en) 2007-09-07
EA016649B1 (ru) 2012-06-29
AU2006334731A1 (en) 2007-07-19
ZA200806938B (en) 2010-02-24
KR20080091366A (ko) 2008-10-10
CA2636837A1 (en) 2007-07-19
IL192596A (en) 2015-07-30
AU2006334731B2 (en) 2012-06-21
WO2007079914A2 (en) 2007-07-19
BRPI0620923A2 (pt) 2011-11-29
CA2636837C (en) 2013-12-10
SI1971339T1 (sl) 2012-07-31
JP5702911B2 (ja) 2015-04-15
CN101355949A (zh) 2009-01-28
AR059030A1 (es) 2008-03-12
CY1112674T1 (el) 2016-02-10
US20100233255A1 (en) 2010-09-16
ATE540682T1 (de) 2012-01-15
EP1971339A2 (en) 2008-09-24
PL1971339T3 (pl) 2012-04-30
FR2896157A1 (fr) 2007-07-20
EP1971339B1 (en) 2012-01-11
FR2896157B1 (fr) 2008-09-12
PT1971339E (pt) 2012-02-20

Similar Documents

Publication Publication Date Title
DK2046791T3 (da) Ureaderivater af tropan, fremstilling deraf og terepeutisk anvendelse deraf
DK2356093T3 (da) Carbazolforbindelser og terapeutiske anvendelser af forbindelserne
DK2114447T3 (da) Forebyggelse og behandling af subkliniks pcvd
EP2231061A4 (en) Implantable prosthesis
DK2865361T3 (da) Tåreimplantater og tilhørende fremgangsmåder
IL196243A0 (en) Fused heterocyclic derivatives and methods of use
DK2445502T4 (da) Heterocycliske forbindelser til behandling af neurologiske og psykologiske lidelser
DK2426106T3 (da) Piperidin- og piperazinderivat til behandling af tumorer
DK2570467T3 (da) Sammensætninger af tetrafluorpropen og carbonhydrider
ZA200806938B (en) Combination of triazine derivatives and insulin secretion stimulators
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
IL196799A0 (en) Fused heterocyclic derivative and use thereof
DK2049614T3 (da) Keramisk proppant med lav vægtfylde
DK3095447T3 (da) Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
DK2262803T3 (da) Polysubstituerede derivater af 2-aryl-6-phenyl-imidazo(1,2-A)pyridiner, fremstilling og terapeutisk anvendelse heraf
DK2254598T3 (da) Kombination af alfa 7-nikotinagonister og antipsykotika
DK2324013T3 (da) Broforbundne piperidinforbindelser af substitueret quinoxalintype og anvendelser deraf
ZA200806947B (en) Combination of triazine derivatives and insulin sensitisers
DK2189537T3 (da) Detektion og behandling af skizofreni
EP2399921A4 (en) Heterocyclic compound and its use
IL196469A0 (en) New medical use of triazine derivatives
DK2382215T3 (da) Derivater af 2-pyridin-2-yl-pyrazol-3(2h)-on, fremstilling og terapeutisk anvendelse heraf
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
DK2235021T3 (da) Epoxyguainderivater og behandling af cancer